Active substance

Results for the substance avalglucosidase alfa

1 result

About this active substance

Avalglucosidase alfa is an enzyme replacement therapy used for the long-term treatment of Pompe disease, a rare genetic condition. In Pompe disease, the body has too little acid alpha-glucosidase, the enzyme that helps break down glycogen. Glycogen build-up can affect the muscles, breathing, and sometimes the heart.

The medicine provides a laboratory-produced form of the missing enzyme. By partly replacing it, avalglucosidase alfa helps cells break down glycogen and may slow muscle and respiratory deterioration. It does not cure Pompe disease, but regular treatment may help preserve physical ability and lung function.

Avalglucosidase alfa is given as an intravenous infusion, usually once every two weeks, and the dose is calculated according to body weight. Infusions should be supervised by a team experienced in metabolic or neuromuscular diseases. In selected stable patients, the doctor may consider home infusions with appropriate training and monitoring.

Common side effects are infusion-related or allergic reactions, such as rash, itching, hives, headache, chills, nausea, tiredness, fever, cough, or breathing discomfort. Severe allergic reactions are uncommon but require urgent help. Tell medical staff immediately if you develop difficulty breathing, facial swelling, severe dizziness, or a feeling that you may faint.